» Articles » PMID: 25410553

Use of Prescribed Opioids by Children and Adolescents: Differences Between Denmark, Norway and Sweden

Overview
Journal Eur J Pain
Publisher Wiley
Date 2014 Nov 21
PMID 25410553
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There are few studies on the use of opioids among children and adolescents. The aim of this study was to determine the 1-year prevalence of prescribed opioid dispensing in Denmark, Norway and Sweden, and to compare gender and age differences in the use of weak and strong opioids between the three countries.

Methods: Data on the dispensing of opioids were collected from the websites of the complete national prescription databases in the three countries. All individuals aged 0-19 with at least one prescription of opioids during the study period were included.

Results: The 1-year prevalence of opioid use among young individuals aged 0-19 years increased during the study period (2006-2012) in Denmark from 2.5 to 3.4 per thousand, in Norway from 10.7 to 13.4 per thousand and in Sweden from 5.9 to 7.1 per thousand. In all three countries, more boys than girls used opioids between the ages of 0 and 10, whereas girls were the major users in the age range 11-19. Use of opioids in all three countries was dominated by weak opioids, codeine being the most dominant in Norway and Sweden and tramadol in Denmark.

Conclusions: The 1-year prevalence of prescribed opioid use among children and adolescents in Norway was far higher than in Denmark and Sweden. During the study period, an increasing use of opioids among children and adolescents was observed in all three countries.

Citing Articles

Health Canada advisory impacts on the prevalence of oral codeine use in the Pediatric Canadian population: comparative study across provinces.

Sheehy O, Eltonsy S, Hawken S, Walker M, Kaul P, Winquist B Sci Rep. 2024; 14(1):5370.

PMID: 38438444 PMC: 10912710. DOI: 10.1038/s41598-024-55758-3.


Opioid Analgesic Prescription in French Children: A National Population-Based Study.

Choufi S, Mounier S, Merlin E, Rochette E, Delorme J, Authier N Int J Environ Res Public Health. 2021; 18(24).

PMID: 34948923 PMC: 8702064. DOI: 10.3390/ijerph182413316.


Development of the Adolescent Opioid Safety and Learning (AOSL) scale using exploratory factor analysis.

Abraham O, Thakur T, Brasel K, Norton D, Rosenberger C Res Social Adm Pharm. 2021; 18(5):2796-2803.

PMID: 34144900 PMC: 9536461. DOI: 10.1016/j.sapharm.2021.06.007.


The Protective and Restorative Effects of Growth Hormone and Insulin-Like Growth Factor-1 on Methadone-Induced Toxicity In Vitro.

Nylander E, Zelleroth S, Nyberg F, Gronbladh A, Hallberg M Int J Mol Sci. 2018; 19(11).

PMID: 30453639 PMC: 6274959. DOI: 10.3390/ijms19113627.


When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.

Rodieux F, Vutskits L, Posfay-Barbe K, Habre W, Piguet V, Desmeules J Front Pharmacol. 2018; 9:148.

PMID: 29556194 PMC: 5844975. DOI: 10.3389/fphar.2018.00148.